MedTrace Logo

Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia

NCT01221584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2012-03-01

No results posted yet for this study

Summary

The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the All-Russian Scientific Cardiology Society guidelines/ the 4th Joint European Task Force guidelines.

Conditions

  • Dyslipidaemia

Sponsors & Collaborators

Principal Investigators

  • Alexey Stepanov, Prof · AstraZeneca

  • Prof. Boytsov · RKNPK

  • Acad Oganov · Center of preventive medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221584 on ClinicalTrials.gov